《Table 6 Biological pathways associated with PD pathogenesis and molecular mechanisms》
提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Translational Informatics for Parkinson's Disease:from Big Biomedical Data to Small Actionable Alterations》
Note:DBL,3,4-dihydroxybenzalacetone;MPTP,1-methyl-4-phenyl-1,2,4,6,-tetrahydropyridine;6-OHDA,6-hydroxydopamine;MPP,1-methyl-4-phenylpyridinium.
PD patients can be treated with levodopa or other dopamine replacement drugs,and surgical approaches,including pallidotomy and thalamotomy,could be alternatives.The responses and side effects of these therapies can be personalized to each patient[77,78].Big data could also provide a direct search and mapping method for the clinical decision of which treatment to use,as shown in Figure 4.However,identifying suitable subpopulations for efficient treatments is always a challenge for clinical application.
图表编号 | XD00117311900 严禁用于非法目的 |
---|---|
绘制时间 | 2019.08.01 |
作者 | Bairong Shen、Yuxin Lin、Cheng Bi、Shengrong Zhou、Zhongchen Bai、Guangmin Zheng、Jing Zhou |
绘制单位 | Institutes for Systems Genetics, West China Hospital, Sichuan University、Center for Systems Biology, Soochow University、Center for Systems Biology, Soochow University、Center for Systems Biology, Soochow University、Center for Translational Biomedical Infor |
更多格式 | 高清、无水印(增值服务) |